Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Study in Patients With Complete Pathological Response After Neoadjuvant Chemotherapy and Negative VABB Biopsy Undergoing RT Alone, Omitting Surgical Treatment

NCT06281210 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06281210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Study in Patients With Complete Pathological Response After Neoadjuvant Chemotherapy and Negative VABB Biopsy Undergoing RT Alone, Omitting Surgical Treatment
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2023
Completion date
December 31, 2028
Enrollment
77 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, her2-positive breast cancer, neoadjuvant chemotherapy, triple negative breast cancer